Perceptions and Feelings of a French Sample Regarding Lung Cancer Screening

Overview

Journal BMC Public Health

Publisher Biomed Central

Specialty Public Health

Date 2023 Nov 24

PMID 38001431

Authors

Nicolas Darnaud

Jean-Eudes Mory

Pascal Romy

Jacques Berger

Karine Eve

Sophie Lantheaume

Affiliations

Soon will be listed here.

Abstract

Introduction: This study investigated the perceptions and feelings of a French sample about the possible introduction of lung cancer screening.

Methods: A total of 146 individuals, aged between 19- and 64-years, participated in this study conducted between November 2020 and January 2021. Participants were divided into three groups according to their smoking status: (i) active smokers (G1); former smokers (G2); and non-smokers (G3). Each individual completed an online questionnaire evaluating their perceptions and feelings about lung cancer, screening and scans.

Results: Overall, a higher percentage of former smokers (47%) indicated a greater willingness to participate in lung cancer screening compared to active smokers (19%) and non-smokers (32%). Active smokers and former smokers reported anxiety about the development of lung cancer. Active smokers who wished to participate in screening reported a greater motivation to reduce their tobacco consumption. The perception of lung cancer risk had less influence than age and socio-economic category on the participation in screening. Finally, stigma did not appear to be a barrier to undergoing screening.

Conclusion: Active and former smokers were generally optimistic about screening; however, active smokers showed less inclination to participate in screening compared to former smokers and non-smokers. Three main factors appeared to influence this participation: the perception of the risk of developing cancer, age and socio-economic category.

References

Dubin R, Kaplan A, Graves L, Ng V . . Can Fam Physician. 2017; 63(12):913-915. PMC: 5729134. View

Tseng T, Gross T, Celestin M, Dang W, Young L, Kao Y . Knowledge and attitudes towards low dose computed tomography lung cancer screening and smoking among African Americans-a mixed method study. Transl Cancer Res. 2022; 8(Suppl 4):S431-S442. PMC: 8797997. DOI: 10.21037/tcr.2019.04.18. View

Rosell R, Karachaliou N . Large-scale screening for somatic mutations in lung cancer. Lancet. 2016; 387(10026):1354-1356. DOI: 10.1016/S0140-6736(15)01125-3. View

Chambers S, Dunn J, Occhipinti S, Hughes S, Baade P, Sinclair S . A systematic review of the impact of stigma and nihilism on lung cancer outcomes. BMC Cancer. 2012; 12:184. PMC: 3517321. DOI: 10.1186/1471-2407-12-184. View

Cataldo J . High-risk older smokers' perceptions, attitudes, and beliefs about lung cancer screening. Cancer Med. 2016; 5(4):753-9. PMC: 4831294. DOI: 10.1002/cam4.617. View

Carter-Harris L, Ceppa D, Hanna N, Rawl S . Lung cancer screening: what do long-term smokers know and believe?. Health Expect. 2015; 20(1):59-68. PMC: 4919238. DOI: 10.1111/hex.12433. View

McRonald F, Yadegarfar G, Baldwin D, Devaraj A, Brain K, Eisen T . The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening. Cancer Prev Res (Phila). 2014; 7(3):362-71. DOI: 10.1158/1940-6207.CAPR-13-0206. View

Horeweg N, Scholten E, de Jong P, van der Aalst C, Weenink C, Lammers J . Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol. 2014; 15(12):1342-50. DOI: 10.1016/S1470-2045(14)70387-0. View

Tod A, Craven J, Allmark P . Diagnostic delay in lung cancer: a qualitative study. J Adv Nurs. 2008; 61(3):336-43. DOI: 10.1111/j.1365-2648.2007.04542.x. View

10.

Rosell R, Gonzalez-Cao M . Ablating lung cancer, knowing the tumor better. Lancet Reg Health Eur. 2022; 22:100494. PMC: 9434033. DOI: 10.1016/j.lanepe.2022.100494. View

11.

Bichsel N, Conus P . [Stigmatisation : a widespread problem with multiple consequences]. Rev Med Suisse. 2017; 13(551):478-481. View

12.

Zeliadt S, Heffner J, Sayre G, Klein D, Simons C, Williams J . Attitudes and Perceptions About Smoking Cessation in the Context of Lung Cancer Screening. JAMA Intern Med. 2015; 175(9):1530-7. DOI: 10.1001/jamainternmed.2015.3558. View

13.

Quaife S, Ruparel M, Beeken R, McEwen A, Isitt J, Nolan G . The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and 'hard-to-reach' patients. BMC Cancer. 2016; 16:281. PMC: 4839109. DOI: 10.1186/s12885-016-2316-z. View

14.

Aberle D, Adams A, Berg C, Black W, Clapp J, Fagerstrom R . Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365(5):395-409. PMC: 4356534. DOI: 10.1056/NEJMoa1102873. View

15.

Horeweg N, van der Aalst C, Vliegenthart R, Zhao Y, Xie X, Scholten E . Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Eur Respir J. 2013; 42(6):1659-67. DOI: 10.1183/09031936.00197712. View

16.

Kummer S, Waller J, Ruparel M, Cass J, Janes S, Quaife S . Mapping the spectrum of psychological and behavioural responses to low-dose CT lung cancer screening offered within a Lung Health Check. Health Expect. 2020; 23(2):433-441. PMC: 7104654. DOI: 10.1111/hex.13030. View

17.

Couraud S, Cortot A, Greillier L, Gounant V, Mennecier B, Girard N . From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the French intergroup (IFCT) and the groupe d'Oncologie de langue.... Ann Oncol. 2012; 24(3):586-97. PMC: 3574545. DOI: 10.1093/annonc/mds476. View

18.

Girard N, Gounant V, Mennecier B, Greillier L, Cortot A, Couraud S . [Individual lung cancer screening in practice. Perspectives on the propositions from the multidisciplinary group of the Intergroupe francophone de cancérologie thoracique, the Société d'imagerie thoracique and the Groupe d'oncologie de langue...]. Rev Mal Respir. 2014; 31(1):91-103. DOI: 10.1016/j.rmr.2013.10.641. View

19.

Flynn A, Peters M, Morgan L . Attitudes towards Lung Cancer Screening in an Australian High-Risk Population. Lung Cancer Int. 2015; 2013:789057. PMC: 4437392. DOI: 10.1155/2013/789057. View

20.

Couraud S, Ferretti G, Milleron B, Cortot A, Girard N, Gounant V . [Recommendations of French specialists on screening for lung cancer]. Rev Mal Respir. 2021; 38(3):310-325. DOI: 10.1016/j.rmr.2021.02.003. View